Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.47 |
| ▸ | FABP4 | P15090 | 1/20 | 0.47 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8926663 | 0.85 | FABP3 (0.47) | FABP3FABP4FABP5ALDH1A1HPGD | |
| SCHEMBL12018139 | 0.81 | FABP3 (0.47) | FABP3FABP4FABP5ALDH1A1HPGD | |
| SCHEMBL1808650 | 0.80 | ALDH1A1 (0.40) | FABP3FABP4FABP5ALDH1A1HPGD | |
| SCHEMBL27952461 | 0.77 | CYP2D6 (0.45) | FABP3FABP4FABP5ALDH1A1HPGD | |
| SCHEMBL11764661 | 0.76 | BRD4 (0.41) | ALDH1A1HPGDLMNACYP1A2GABRA1 | |
| SCHEMBL19194608 | 0.76 | TRPA1 (0.38) | ALDH1A1HPGDLMNACA1CA2 | |
| SCHEMBL26028062 | 0.76 | FABP3 (0.48) | FABP3FABP4FABP5ALDH1A1HPGD | |
| SCHEMBL6734425 | 0.76 | FABP3 (0.48) | FABP3FABP4FABP5HPGDLMNA | |
| SCHEMBL1494556 | 0.75 | GABRA1 (0.56) | ALDH1A1HPGDLMNASLC6A2HTR2B | |
| SCHEMBL2742118 | 0.74 | FABP3 (0.61) | FABP3FABP4FABP5HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060939-A1 | TREATMENT FOR MANAGEMENT AND PREVENTION OF EYELID CONDITIONS | OLKOWSKI JOHN (US) | 2026-03-05 | — | — | US | disclosed |
| WO-2024078917-A1 | BIOPESTICIDE COMPOSITION WITH SYNERGISTIC EFFECT AND METHOD FOR COMBATING AND CONTROLLING PESTS | Kimitec Biogroup S.L (ES) | 2024-04-18 | — | — | WO | disclosed |
| EP-4353084-A1 | BIOPESTICIDE COMPOSITION WITH SYNERGISTIC EFFECT AND METHOD FOR COMBATING AND CONTROLLING PESTS | Kimitec Biogroup S.L (ES) | 2024-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060939-A1 | TREATMENT FOR MANAGEMENT AND PREVENTION OF EYELID CONDITIONS | DAGLB, CNR2, PPARD | FABP3 1341/4885FABP4 260/4885FABP5 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.